Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS

被引:55
作者
Wenner, BR
Lovell, MA
Lynn, BC [1 ]
机构
[1] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
关键词
cerebrospinal fluid; CSF; proteomics; two-dimensional chromatography; 2-D LC-MS/MS; Alzheimer's Disease; biomarkers;
D O I
10.1021/pr034070r
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A two-dimensional liquid chromatography separation scheme coupled to tandem mass spectrometry (2-D LC-MS/MS) was utilized to profile the proteome of human CSF. Ventricular CSF samples acquired post-mortem from 10 cognitively normal elderly subjects (mean +/- SEM Braak stage = 1.7 +/- 0.2) were analyzed to determine their protein composition. Raw CSF samples were subjected to an immunobased processing method to remove highly abundant albumin and immunoglobulin (Ig), allowing better detection of lower-abundance proteins. Samples were subjected to trypsin proteolysis followed by C18 solid-phase extraction. Tryptic CSF peptides were separated using a 2-D LC column, in which both strong cation exchange (SCX) and C18 phases were packed into a single capillary. MS/MS spectra of CSF peptides were searched against a human sub-database of the NBCI nonredundant database using the SEQUEST algorithm. Search results were further filtered using DTAselect, and individual samples were compared to one another using Contrast. Using this method, we were able to unambiguously identify 249 CSF proteins from 10 subjects. Of these proteins, 38% were unique to individual subjects, whereas only 6% were common to all 10 subjects. These results suggest considerable subject-to-subject variability in the CSF proteome.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 55 条
[1]   Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients [J].
Almer, G ;
Teismann, P ;
Stevic, Z ;
Halaschek-Wiener, J ;
Deecke, L ;
Kostic, V ;
Przedborski, S .
NEUROLOGY, 2002, 58 (08) :1277-1279
[2]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[3]   Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379
[4]  
[Anonymous], NEUROBIOLOGY CEREBRO
[5]  
[Anonymous], 1980, CEREBROSPINAL FLUID
[6]  
[Anonymous], 1994, NEURODEGENER DIS
[7]   Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry [J].
Bergquist, J ;
Palmblad, M ;
Wetterhall, M ;
Håkansson, P ;
Markides, KE .
MASS SPECTROMETRY REVIEWS, 2002, 21 (01) :2-15
[8]   Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease [J].
Bernal, F ;
Shams'ili, S ;
Rojas, I ;
Sanchez-Valle, R ;
Saiz, A ;
Dalmau, J ;
Honnorat, J ;
Smitt, PS ;
Graus, F .
NEUROLOGY, 2003, 60 (02) :230-234
[9]   tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease? [J].
Blennow, K ;
Wallin, A ;
Agren, H ;
Spenger, C ;
Siegfried, J ;
Vanmechelen, E .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) :231-245
[10]   Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease [J].
Bonelli, RM ;
Aschoff, A ;
Niederwieser, G ;
Heuberger, C ;
Jirikowski, G .
NEUROBIOLOGY OF DISEASE, 2002, 11 (01) :106-110